Maltz Jules A. 4
4 · Hims & Hers Health, Inc. · Filed Mar 17, 2023
Insider Transaction Report
Form 4
Maltz Jules A.
Director
Transactions
- Exercise/Conversion
Class A Common Stock
2023-03-15+2,449→ 20,863 total - Exercise/Conversion
Restricted Stock Unit
2023-03-15−4→ 35 total→ Class A Common Stock (4 underlying) - Exercise/Conversion
Restricted Stock Unit
2023-03-15−218→ 1,743 total→ Class A Common Stock (218 underlying) - Exercise/Conversion
Restricted Stock Unit
2023-03-15−2,227→ 17,814 total→ Class A Common Stock (2,227 underlying)
Holdings
- 220,401(indirect: By Jules Maltz and Kelly Greenwood Fam Tr UA 07/31/2018)
Class A Common Stock
- 40,735(indirect: By Institutional Venture Partners XV Executive Fund, L.P.)
Class A Common Stock
- 7,707,291(indirect: By Institutional Venture Partners XVI, L.P.)
Class A Common Stock
- 1,224(indirect: By LLC)
Class A Common Stock
- 1,225(indirect: By LLC)
Class A Common Stock
- 7,666,545(indirect: By Institutional Venture Partners XV, L.P.)
Class A Common Stock
Footnotes (3)
- [F1]The Restricted Stock Units ("RSUs") represent a contingent right to receive one share of Class A Common Stock for each RSU.
- [F2]Mr. Maltz is a managing director of Institutional Venture Management XV LLC, which is the general partner of Institutional Venture Partners XV Executive Fund, L.P. ("IVP XV Executive Fund") and Institutional Venture Partners XV, L.P. ("IVP XV"), and Institutional Venture Management XVI LLC, which is the general partner of Institutional Venture Partners XVI, L.P. ("IVP XVI"). Mr. Maltz may be deemed a beneficial owner of the securities held by IVP XV Executive Fund, IVP XV and IVP XVI, but disclaims beneficial ownership thereof, except to the extent of any pecuniary interest therein.
- [F3]The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a four-year period, with 25% of the RSUs vesting on the first Company Quarterly Vesting Date (as defined below) occurring on or after the one-year anniversary of March 15, 2021. The remaining 75% vest in equal quarterly installments over the following three years, on the specified vesting dates of March 15, June 15, September 15 and December 15 (each, a "Company Quarterly Vesting Date").